Luis I Ruffolo

7PUBLICATIONS
25CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsOther psychology not elsewhere classifiedCancer geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 15, 2025
Rethinking surrogate endpoints in metastatic colorectal cancer: counting chickens only when they hatch.

Luis I Ruffolo, Michael D'Angelica

|Aug 05, 2024
Pan-lysyl oxidase inhibition disrupts fibroinflammatory tumor stroma, rendering cholangiocarcinoma susceptible to chemotherapy.

Paul R Burchard, Luis I Ruffolo, Nicholas A Ullman

|Jul 08, 2024
Reply to A. Jain et al.

Mariana Chávez-Villa, Luis I Ruffolo, Matthew Byrne

|Feb 28, 2024
Smad4 restricts injury-provoked biliary proliferation and carcinogenesis.

William B Alexander, Wenjia Wang, Margaret A Hill

|Feb 26, 2024
Emerging Role of Liver Transplantation for Unresectable Colorectal Liver Metastases.

Mariana Chávez-Villa, Luis I Ruffolo, Pål-Dag Line

|Apr 25, 2022
What is the optimal prophylaxis against postoperative deep vein thrombosis in the living donor to avoid complications and enhance recovery? - A systematic review of the literature and expert panel recommendations.

Luis I Ruffolo, Mark Levstik, Jen Boehly

Pageof 2

Frequent Collaborators

3 joint publications

Roberto Hernandez-Alejandro

2 joint publications

Aram F Hezel

2 joint publications

Mariana Chávez-Villa

2 joint publications

Pål-Dag Line